Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics
Headquartered in Boston, Mass., Entrada is a private company that closed on its Series A in December 2018. To date, Entrada has raised over $50 million from 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund and Agent Capital.
At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platforms to yield treatments for patients in need.
We genuinely care about patients and about one another
We’re relentless and persistent in the pursuit of developing therapies for patients
We’re creative problem solvers
We’re more than the sum of our parts
We’ve got a growth mindset
Join our team if you share our values, our devotion to science and our passion for helping patients.
What makes Entrada a great place to work is its high-energy environment, complemented by our employees’ shared desire to make a difference in science and on patients.Leo Qian, Co-founder and Director, Discovery Research
At Entrada, we value intellectual curiosity and enjoy the challenge of fighting the good fight: waking up each day to advance our science one step closer to helping patients and their caregivers who deserve better treatments.Dipal Doshi, President and Chief Executive Officer
Boston, MALearn more